{"transactions":[{"id":677293,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-08-24T21:30:03.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":4345,"price":11.8903,"value":51663.3535,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $11.78 to $12.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":169269,"source":{"system":"sec-edgar","filing":"0001193125-26-363810","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526363810/ownership.xml","form_type":"4"}},{"id":765756,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-22T20:05:07.000Z","date":"2026-05-21","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":11,"value":110000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025."}],"balance_after":173614,"source":{"system":"sec-edgar","filing":"0001193125-26-236838","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526236838/ownership.xml","form_type":"4"}},{"id":769868,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-20T20:05:22.000Z","date":"2026-05-19","kind":"sale","planned":true,"acquired":false,"shares":339,"price":9.21,"value":3122.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"678 shares were acquired on May 17, 2026 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":183614,"source":{"system":"sec-edgar","filing":"0001193125-26-232547","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526232547/ownership.xml","form_type":"4"}},{"id":929920,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:08.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":1572,"price":8.4607,"value":13300.2204,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24."}],"balance_after":183275,"source":{"system":"sec-edgar","filing":"0001193125-26-025305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526025305/ownership.xml","form_type":"4"}},{"id":929919,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:08.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":4842,"price":8.4606,"value":40966.2252,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25."}],"balance_after":184847,"source":{"system":"sec-edgar","filing":"0001193125-26-025305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526025305/ownership.xml","form_type":"4"}},{"id":946211,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Option to purchase common stock","published_at":"2026-01-06T21:30:07.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":100000,"derivative":{"exercise_price":10.335,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-26-004564","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526004564/ownership.xml","form_type":"4"}},{"id":946210,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:30:07.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30."}],"balance_after":189689,"source":{"system":"sec-edgar","filing":"0001193125-26-004564","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526004564/ownership.xml","form_type":"4"}},{"id":998805,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:08.000Z","date":"2025-11-14","kind":"sale","planned":false,"acquired":false,"shares":8887,"price":11.1769,"value":99329.1103,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 11/13/25."}],"balance_after":139689,"source":{"system":"sec-edgar","filing":"0001193125-25-283564","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525283564/ownership.xml","form_type":"4"}},{"id":998804,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:08.000Z","date":"2025-11-13","kind":"grant","planned":false,"acquired":true,"shares":48900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest 50% immediately and 50% on 11/13/26."}],"balance_after":148576,"source":{"system":"sec-edgar","filing":"0001193125-25-283564","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525283564/ownership.xml","form_type":"4"}},{"id":1031161,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:10.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":8891,"price":8.9422,"value":79505.1002,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 9/27/25."}],"balance_after":99676,"source":{"system":"sec-edgar","filing":"0001193125-25-223667","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525223667/ownership.xml","form_type":"4"}},{"id":1031160,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:10.000Z","date":"2025-09-27","kind":"grant","planned":false,"acquired":true,"shares":48900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":108567,"source":{"system":"sec-edgar","filing":"0001193125-25-223667","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525223667/ownership.xml","form_type":"4"}},{"id":1292961,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-01-29T01:38:11.000Z","date":"2025-01-28","kind":"sale","planned":false,"acquired":false,"shares":1583,"price":7.8719,"value":12461.2177,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24."}],"balance_after":59667,"source":{"system":"sec-edgar","filing":"0000950170-25-010116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025010116/ownership.xml","form_type":"4"}},{"id":1310324,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Option to purchase common stock","published_at":"2025-01-06T21:07:04.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":92500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":92500,"derivative":{"exercise_price":8.68,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":92500},"source":{"system":"sec-edgar","filing":"0000950170-25-002056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025002056/ownership.xml","form_type":"4"}},{"id":1310323,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-01-06T21:07:04.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":46250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/26, 1/26/27, 1/26/28 and 1/26/29."}],"balance_after":61250,"source":{"system":"sec-edgar","filing":"0000950170-25-002056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025002056/ownership.xml","form_type":"4"}},{"id":1687550,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Option to purchase common stock","published_at":"2024-01-04T21:07:45.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":30000,"derivative":{"exercise_price":15.36,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-001849","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024001849/ownership.xml","form_type":"4"}},{"id":1687549,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-01-04T21:07:45.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/25, 1/26/26, 1/26/27 and 1/26/28."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0000950170-24-001849","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024001849/ownership.xml","form_type":"4"}},{"id":1805463,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Option to purchase common stock","published_at":"2023-08-16T20:09:43.000Z","date":"2023-08-14","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest on the one year anniversary of the vesting commencement date, and 1/48th of the shares vest in 36 monthly installments thereafter."}],"balance_after":200000,"derivative":{"exercise_price":11.72,"expiration_date":"2033-08-13","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-23-046002","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123046002/doc4.xml","form_type":"4"}},{"id":1833701,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-07-06T21:19:21.000Z","date":"2023-07-05","kind":"sale","planned":false,"acquired":false,"shares":3854,"price":4.87,"value":18768.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 11,250 shares of Common Stock underlying RSUs granted to the Reporting Person on June 27, 2022. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $4.82 to $4.94 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth this footnote."}],"balance_after":41146,"source":{"system":"sec-edgar","filing":"0001209191-23-041611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919123041611/doc4.xml","form_type":"4"}},{"id":2028300,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-07T21:16:46.000Z","date":"2023-02-06","kind":"grant","acquired":true,"shares":425000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2023, such that all of the shares shall be fully vested and exercisable on January 1, 2026, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":425000,"derivative":{"exercise_price":6.77,"expiration_date":"2033-02-05","underlying":"Common Stock","underlying_shares":425000},"source":{"system":"sec-edgar","filing":"0001209191-23-007507","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919123007507/doc4.xml","form_type":"4"}},{"id":2219317,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T21:02:35.000Z","date":"2022-06-27","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest as to 25% of the underlying shares on June 27, 2023 and thereafter on a monthly basis for 36 additional months, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date."}],"balance_after":70000,"derivative":{"exercise_price":26.25,"expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-22-039819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122039819/doc4.xml","form_type":"4"}},{"id":2219316,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":20320,"kind":"person","name":"Powl Brian T.","position":1,"cik":"0001934232","reported_name":"Powl Brian T.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-06-29T21:02:35.000Z","date":"2022-06-27","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exempt grant of restricted stock units pursuant to the Issuer's Amended and Restated Inducement Equity Plan. 25% of the award will vest on July 1, 2023, and 25% of the remainder shall vest on July 1, 2024, July 1, 2025, and July 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date."}],"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001209191-22-039819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122039819/doc4.xml","form_type":"4"}}]}